BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22225872)

  • 21. The role of interleukin-1 in allergy-related disorders.
    Krause K; Metz M; Makris M; Zuberbier T; Maurer M
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):477-84. PubMed ID: 22885885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance in the defense against obesity.
    Saltiel AR
    Cell Metab; 2012 Jun; 15(6):798-804. PubMed ID: 22682220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inflammasome in atherosclerosis and type 2 diabetes.
    Masters SL; Latz E; O'Neill LA
    Sci Transl Med; 2011 May; 3(81):81ps17. PubMed ID: 21543720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the inflammasome in myocardial infarction.
    Takahashi M
    Trends Cardiovasc Med; 2011 Feb; 21(2):37-41. PubMed ID: 22578238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes.
    Bae JH; Jo SI; Kim SJ; Lee JM; Jeong JH; Kang JS; Cho NJ; Kim SS; Lee EY; Moon JS
    Cells; 2019 Apr; 8(4):. PubMed ID: 30965677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.
    Hardaway AL; Podgorski I
    Future Med Chem; 2013 Jun; 5(10):1089-108. PubMed ID: 23795967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 2 diabetes mellitus: a metabolic autoinflammatory disease.
    Mandrup-Poulsen T
    Dermatol Clin; 2013 Jul; 31(3):495-506. PubMed ID: 23827251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is caspase 1 central to activation of interleukin-1?
    Wittmann M; Kingsbury SR; McDermott MF
    Joint Bone Spine; 2011 Jul; 78(4):327-30. PubMed ID: 21459652
    [No Abstract]   [Full Text] [Related]  

  • 29. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.
    Herder C; Dalmas E; Böni-Schnetzler M; Donath MY
    Trends Endocrinol Metab; 2015 Oct; 26(10):551-563. PubMed ID: 26412156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of resistin with obesity with type 2 diabetes].
    Wang WY; Zhu S; Yang JC
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):157-60. PubMed ID: 19558147
    [No Abstract]   [Full Text] [Related]  

  • 31. Inflammasomes: Cause or consequence of obesity-associated comorbidities in humans.
    Herrera-Martínez AD; Herrero-Aguayo V; Pérez-Gómez JM; Gahete MD; Luque RM
    Obesity (Silver Spring); 2022 Dec; 30(12):2351-2362. PubMed ID: 36415999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking the inflammasome to obesity-related disease.
    Horng T; Hotamisligil GS
    Nat Med; 2011 Feb; 17(2):164-5. PubMed ID: 21297609
    [No Abstract]   [Full Text] [Related]  

  • 33. A protective role for inflammasome activation following injury--Shock 2012;37(1): 47-55.
    Winkler S; Heymann MC; Franke M; Martin A; Roesler J; Rösen-Wolff A
    Shock; 2012 Jun; 37(6):659; author reply 659-60. PubMed ID: 22592636
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis.
    Alfadul H; Sabico S; Al-Daghri NM
    Front Endocrinol (Lausanne); 2022; 13():901616. PubMed ID: 35966098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conversation with Barbara Kahn.
    Neill US
    J Clin Invest; 2020 Mar; 130(3):1053-1054. PubMed ID: 32118587
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of Tissue and Systemic Hypoxia in Obesity and Type 2 Diabetes.
    Xi L; Chow CM; Kong X
    J Diabetes Res; 2016; 2016():1527852. PubMed ID: 27419143
    [No Abstract]   [Full Text] [Related]  

  • 37. A long and stony road to the correct treatment of obesity.
    Lecube A; Ciudin A
    Med Clin (Barc); 2021 Aug; 157(4):176-177. PubMed ID: 34253348
    [No Abstract]   [Full Text] [Related]  

  • 38. Obesity and epilepsy: The first step of a long road.
    Hafizi N; Alipoor E; Hosseinzadeh-Attar MJ
    Epilepsy Behav; 2017 Feb; 67():135-136. PubMed ID: 28087251
    [No Abstract]   [Full Text] [Related]  

  • 39. The Heart and its Danger in the Treatment of Obesity.
    Curtin RG
    Trans Am Climatol Assoc; 1908; 24():163-76. PubMed ID: 21408470
    [No Abstract]   [Full Text] [Related]  

  • 40. ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis.
    Joukar S; Rajizadeh MA; Bejeshk MA; Alavi SS; Bagheri F; Rami M; Khoramipour K
    Sci Rep; 2024 Mar; 14(1):7113. PubMed ID: 38532054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.